Home | Erectile Dysfunction | Erectile issues more likely in men with type-2 diabetes

Erectile issues more likely in men with type-2 diabetes

Reviewed By,

Written By,

Reviewed By,

Written By,

ED TREATMENTS

Effective ED Treatment. Private. Convenient. Trusted.

Doctor-prescribed ED medication delivered discreetly to your door.

Licensed U.S.
Physicians
Discreet &
Private
Fast, Discreet
Delivery
ED3 Max dissolvable ED pills
TADALAFIL

ED3 Max Dissolvable ED Pills

Long-lasting results up to 36 hours.

  • Up to 36 Hour Window
  • Improved Confidence
  • Works When You Need It
$129/ 10 pills
View Treatment
Sildenafil citrate tablets
SILDENAFIL

Sildenafil 25mg

Proven effective treatment.

  • Starts Working in 30–60 Min
  • Effective, As Needed
  • Trusted & Reliable
$99/ 20 pills
View Treatment
ED4 Chew Gum
TADALAFIL

ED4 Chew Gum

Low daily dose for continuous readiness.

  • Taken Once Daily
  • Continuous Readiness
  • Improves Confidence
$99/ 30 pills
View Treatment
100% Confidential
Your privacy is our priority.
Physician Reviewed
Care by licensed specialists.
Discreet Delivery
Plain packaging. Fast shipping.
Satisfaction Guaranteed
We're here to help.

According to a study recently conducted in Bursa, Turkey, erectile issues are significantly more prevalent in men with type 2 diabetes than in healthy men in the same age group.

For the study, researchers evaluated 116 men seen in 2012 and 2013 at a tertiary care hospital in Bursa, Turkey. The study population comprised 68 men with type 2 diabetes (mean age, 56.7 years) and 48 healthy controls (mean age, 57 years). Additionally, the researchers recorded BMI and blood biochemistry data for each participant. The researchers also evaluated coexisting hypertension, hyperlipidemia, coronary artery disease, carotid artery intima-media thickness (CIMT) in each participant.

The researchers found similar rates of hyperlipidemia in the diabetic (51.5%) and control groups (39.6%) as well as comparable rates of CAD (33.8% in the diabetic group and 22.9% in the control group). However, there was a significantly higher rate of hypertension (P=.05) in the patients with diabetes vs. control patients and significantly higher CIMT values (P=.02) in patients with diabetes vs. control patients. Among the patients with diabetes, 46.2% were determined to have polyneuropathy, 30.8% had nephropathy and 33.8% had retinopathy. The patients with diabetes had significantly lower erectile health scores than the controls (14.3% vs. 18.3%; P=.014). Diabetic polyneuropathy was determined by univariate analysis to be the only risk factor linked to increased likelihood of ED (93.3% when neuropathy was present vs. 60% when neuropathy was absent) as well as severity of erectile issues (43.3% when neuropathy was present vs. 14.3% when neuropathy was absent, P=.004).

According to the researchers, further studies are needed to better understand the interrelated pathogenic factors related to endothelial dysfunction-related erectile issues in type 2 diabetes. They also wrote that these findings suggest the need for erectile health screening in patients with diabetes.

Special Offers on Treatments and Products